Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

HIGHLIGHTS

• who: Vermersch et_al BMC Neurology et al. from the Hôpital Roger Salengro, CHU de Lille, Lille , France Department of, University of Lille Nord de France (EA2686) have published the research work: Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study, in the Journal: (JOURNAL)
• what: In view of the pressing medical need for an effective treatment in progressive forms of MS, if this were the case then the primary objective to demonstrate acceptable safety and possible therapeutic response, i.e. establish proof-of-concept, would have been sufficiently accomplished, thereby enabling . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.